Ludovic Trinquart

researcher

Born 1980-01-01

Ludovic Trinquart is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID01274005350.01
P2671Google Knowledge Graph ID/g/11f66_l35f
P269IdRef ID176324879
P549Mathematics Genealogy Project ID246615
P4955MR Author ID1168288
P496ORCID iD0000-0002-3028-4900
P3829Publons author ID707827
P1053ResearcherIDH-4961-2019
P1153Scopus author ID24074873600
P214VIAF cluster ID306485546

P184doctoral advisorGilles ChatellierQ89284751
P185doctoral studentIsabelle R WeirQ103230849
P69educated atParis Descartes UniversityQ1155944
P108employerBoston University School of Public HealthQ4948185
Tufts Medical CenterQ7851542
Tufts University School of MedicineQ7851551
P735given nameLudovicQ7135568
LudovicQ7135568
P106occupationbiostatisticianQ52899051
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q47185073A hand-held ultrasound machine vs. conventional ultrasound machine in the bedside assessment of post-liver transplant patients
Q48513585A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non-high-income regions
Q24288963A test for reporting bias in trial networks: simulation and case studies
Q40135354Accuracy of multi-detector computed tomographic angiography assisted by post-processing software for diagnosis atheromatous renal artery stenosis.
Q31100974Adjustment for reporting bias in network meta-analysis of antidepressant trials
Q27022649Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review
Q37823807Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review
Q46678565Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events
Q57779668Assessment of Heterogeneity in Meta-analyses—Reply
Q104610284Association Between Frailty and Atrial Fibrillation in Older Adults: The Framingham Heart Study Offspring Cohort
Q47097420Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study
Q45303903Association between analytic strategy and estimates of treatment outcomes in meta-analyses
Q101406721Associations Between Alcohol Intake and Genetic Predisposition with Atrial Fibrillation Risk in a National Biobank
Q91605381Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke
Q60309353Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
Q36141947Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries
Q33712984Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?
Q46745542Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Q53123375Commentary: Meta-epidemiology, meta-meta-epidemiology or network meta-epidemiology?
Q85487372Comparative effectiveness of cryotherapy and salicylic acid for plantar warts
Q90412603Comparison of On-Site Versus Remote Mobile Device Support in the Framingham Heart Study Using the Health eHeart Study for Digital Follow-up: Randomized Pilot Study Set Within an Observational Study Design
Q39991781Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials
Q24186056Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates
Q24186824Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates
Q28533341Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study
Q53127473Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures
Q57249894Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study
Q31043561Complex systems approach to scientific publication and peer-review system: development of an agent-based model calibrated with empirical journal data
Q24202497Computerized advice on drug dosage to improve prescribing practice
Q24242619Computerized advice on drug dosage to improve prescribing practice
Q53058057Coronary artery stenosis in high-risk patients: 64-section CT and coronary angiography--prospective study and analysis of discordance
Q79745002Coronary heart disease and associated risk factors in sub-Saharan Africans
Q58481438Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure*
Q63811741Design and Preliminary Findings From a New Electronic Cohort Embedded in the Framingham Heart Study
Q91383278Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records
Q84181461Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening
Q35866990Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials
Q37815949Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches
Q35789966Early respiratory acidosis is a new risk factor for pneumonia after lung resection
Q44813865Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism.
Q38824207Empirical evaluation of which trial characteristics are associated with treatment effect estimates
Q34822291Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.
Q47308086Endoluminal gingival fibroblast transfer reduces the size of rabbit carotid aneurisms via elastin repair.
Q42698230Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication
Q36396374Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study
Q83338275Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Q36065115Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?
Q89320643Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults
Q44264994Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass
Q50054227Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
Q51683132Hakki's formula for measurement of aortic valve area by magnetic resonance imaging
Q24197782High-intensity versus low-intensity physical activity or exercise in patients with hip or knee osteoarthritis
Q24186301High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis
Q28482475Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials
Q54576614Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria.
Q34483629Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
Q30249679Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis
Q41111726Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
Q84294871Increased intensity of treatment and decreased mortality in elderly patients in an intensive care unit over a decade
Q53164937Influence of age on the risk of severe exacerbation and asthma control in childhood
Q27687577Influence of trial sample size on treatment effect estimates: meta-epidemiological study
Q89801307Initial Precipitants and Recurrence of Atrial Fibrillation
Q91694190Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation
Q48540046International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-lif
Q51024974Knowledge of oral drug treatment in immunocompromised patients on hospital discharge
Q85019476Letter by Naggara et al Regarding Article, “Are Distal Protection Devices ‘Protective' During Carotid Angioplasty and Stenting?”
Q55312807Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
Q28597805Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor
Q84546636Lung function impairment evidenced by sequential specific airway resistance in childhood persistent asthma: a longitudinal study
Q39006379Mapping epidemiology's past to inform its future: metaknowledge analysis of epidemiologic topics in leading journals, 1974-2013.
Q37579635Mechanical ventilation and clinical practice heterogeneity in intensive care units: a multicenter case-vignette study
Q47420329Mental health surveillance after the terrorist attacks in Paris.
Q35886848Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture
Q43020663Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
Q84758603Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity
Q46626413New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases
Q46802231Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up
Q90756689Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort
Q41976121One-year experience with high-emergency lung transplantation in France
Q43248494Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib.
Q24194490Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients
Q44594574Outcomes in older patients after surgical treatment for hip fracture: a new approach to characterise the link between readmissions and the surgical stay
Q83170137Partitioning of exhaled NO in ventilated patients undergoing cardiac surgery
Q104138544Performance of Atrial Fibrillation Risk Prediction Models in Over Four Million Individuals
Q83200032Perfusion defects after pulmonary embolism: risk factors and clinical significance
Q44335394Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis
Q82923086Prediction of nosocomial infection acquisition in ventilated patients by nasal nitric oxide: proof-of-concept study
Q108910588Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation
Q57249886Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF study
Q34600450Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Q48409194Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study
Q37170044Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review.
Q92665292Protein Biomarkers and Risk of Atrial Fibrillation: The FHS
Q62666876Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
Q57249891Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study
Q92479676Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival Times
Q33432723Relationships between specific airway resistance and forced expiratory flows in asthmatic children
Q57286324Reply to Letter
Q38195122Reporting of results from network meta-analyses: methodological systematic review
Q34425153Respective contribution of chronic conditions to disability in France: results from the national Disability-Health Survey
Q83395615Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study
Q41471697Sample size calculation for meta-epidemiological studies.
Q45228027Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study
Q126090280Step Count, Self-reported Physical Activity, and Predicted 5-Year Risk of Atrial Fibrillation: Cross-sectional Analysis
Q37628336Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting.
Q37926800Terminology for the description of the diagnostic studies in the field of EBM.
Q27886969The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise
Q34010010The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
Q27687356The Volume-Outcome Relationship in Critical Care: A Systematic Review and Meta-analysis
Q26853062The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials
Q83065089The link between exhaled NO and bronchomotor tone depends on the dose of inhaled steroid in asthma
Q37583248Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.
Q98388544Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
Q35992642Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials.
Q34221473Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs
Q45934887Volume-outcome relationship in critical care: a systematic review.
Q35899612Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer
Q43253490What does a single exhaled nitric oxide measurement tell us in asthmatic children?
Q38738299Why do we think we know what we know? A metaknowledge analysis of the salt controversy
Q95001949[Drug-eluting stents: do we respect the on-label use in our daily practice?]
Q83831310[Hospital LOS, medical complexity and deprivation indicators]

Q103230849Isabelle R Weirdoctoral advisorP184
Q89284751Gilles Chatellierdoctoral studentP185

Search more.